Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

11

Number of overlapping holdings

45.8%

% of PPH's 27 holdings also in XLV

17.7%

% of XLV's 62 holdings also in PPH

Overlap by Weight
Sector Drift (PPH minus XLV)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PPH
Weight
in XLV
Overlap
ELI LILLY & CO 11.9% 11.3% 11.3%
JOHNSON & JOHNSON 6.8% 7.1% 6.8%
ABBVIE INC 5.7% 5.6% 5.6%
MERCK & CO. INC. 4.8% 4.7% 4.7%
PFIZER INC 4.2% 2.7% 2.7%

Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XLV
NOVO-NORDISK A/S-SPONS ADR 7.8%
NOVARTIS AG-ADR 5.0%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS 4.6%
MCKESSON CORP 4.5%
ASTRAZENECA PLC-SPONS ADR 4.4%
AMERISOURCEBERGEN CORP 4.3%
SANOFI-AVENTIS-ADR 4.2%
GLAXOSMITHKLINE PLC-SPON ADR 3.8%
BRISTOL-MYERS SQUIBB CO 3.6%
TEVA PHARMACEUTICAL-SP ADR 3.6%
PPH Underweight Relative to XLV
UNITEDHEALTH GROUP INC -10.5%
ABBOTT LABORATORIES -3.9%
THERMO FISHER SCIENTIFIC INC -3.8%
INTUITIVE SURGICAL INC -3.6%
AMGEN INC -2.9%
DANAHER CORP -2.8%
STRYKER CORP -2.6%
BOSTON SCIENTIFIC CORP -2.5%
VERTEX PHARMACEUTICALS INC -2.3%
MEDTRONIC PLC -2.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY